S&P 500   3,188.11 (-1.17%)
DOW   27,640.00 (-1.15%)
QQQ   218.93 (-1.11%)
AAPL   294.67 (-1.18%)
FB   199.75 (-0.48%)
MSFT   171.07 (+0.11%)
GOOGL   1,415.46 (-0.31%)
AMZN   1,988.71 (-1.02%)
CGC   19.74 (-2.76%)
NVDA   260.70 (-4.60%)
BABA   206.33 (+0.08%)
MU   52.93 (-3.78%)
GE   11.51 (-2.95%)
TSLA   796.74 (-4.44%)
AMD   48.12 (-2.04%)
T   38.07 (+0.05%)
F   7.47 (-1.32%)
NFLX   360.43 (-2.24%)
BAC   31.94 (-2.41%)
DIS   130.44 (-1.93%)
GILD   69.80 (-4.25%)
S&P 500   3,188.11 (-1.17%)
DOW   27,640.00 (-1.15%)
QQQ   218.93 (-1.11%)
AAPL   294.67 (-1.18%)
FB   199.75 (-0.48%)
MSFT   171.07 (+0.11%)
GOOGL   1,415.46 (-0.31%)
AMZN   1,988.71 (-1.02%)
CGC   19.74 (-2.76%)
NVDA   260.70 (-4.60%)
BABA   206.33 (+0.08%)
MU   52.93 (-3.78%)
GE   11.51 (-2.95%)
TSLA   796.74 (-4.44%)
AMD   48.12 (-2.04%)
T   38.07 (+0.05%)
F   7.47 (-1.32%)
NFLX   360.43 (-2.24%)
BAC   31.94 (-2.41%)
DIS   130.44 (-1.93%)
GILD   69.80 (-4.25%)
S&P 500   3,188.11 (-1.17%)
DOW   27,640.00 (-1.15%)
QQQ   218.93 (-1.11%)
AAPL   294.67 (-1.18%)
FB   199.75 (-0.48%)
MSFT   171.07 (+0.11%)
GOOGL   1,415.46 (-0.31%)
AMZN   1,988.71 (-1.02%)
CGC   19.74 (-2.76%)
NVDA   260.70 (-4.60%)
BABA   206.33 (+0.08%)
MU   52.93 (-3.78%)
GE   11.51 (-2.95%)
TSLA   796.74 (-4.44%)
AMD   48.12 (-2.04%)
T   38.07 (+0.05%)
F   7.47 (-1.32%)
NFLX   360.43 (-2.24%)
BAC   31.94 (-2.41%)
DIS   130.44 (-1.93%)
GILD   69.80 (-4.25%)
S&P 500   3,188.11 (-1.17%)
DOW   27,640.00 (-1.15%)
QQQ   218.93 (-1.11%)
AAPL   294.67 (-1.18%)
FB   199.75 (-0.48%)
MSFT   171.07 (+0.11%)
GOOGL   1,415.46 (-0.31%)
AMZN   1,988.71 (-1.02%)
CGC   19.74 (-2.76%)
NVDA   260.70 (-4.60%)
BABA   206.33 (+0.08%)
MU   52.93 (-3.78%)
GE   11.51 (-2.95%)
TSLA   796.74 (-4.44%)
AMD   48.12 (-2.04%)
T   38.07 (+0.05%)
F   7.47 (-1.32%)
NFLX   360.43 (-2.24%)
BAC   31.94 (-2.41%)
DIS   130.44 (-1.93%)
GILD   69.80 (-4.25%)
Log in

TRACON Pharmaceuticals SEC Filings & 10K Form (NASDAQ:TCON)

$3.48
-0.14 (-3.86 %)
(As of 02/25/2020 11:08 AM ET)
Today's Range
$3.48
Now: $3.48
$3.70
50-Day Range
$2.40
MA: $3.75
$4.40
52-Week Range
$2.07
Now: $3.48
$17.30
Volume44,401 shs
Average Volume763,000 shs
Market Capitalization$10.93 million
P/E RatioN/A
Dividend YieldN/A
Beta2

SEC Filings

TRACON Pharmaceuticals (NASDAQ:TCON) SEC Filings

DateFilerForm TypeView
02/10/2020
7:15 AM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2020
3:12 PM
Brown Scott B. (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
3:11 PM
TRACON Pharmaceuticals (Issuer)
WIGGINS MARK C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
3:10 PM
THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
3:10 PM
TRACON Pharmaceuticals (Issuer)
WIGGINS MARK C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
3:09 PM
Brown Scott B. (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
3:08 PM
THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
3:01 PM
Linden Capital L.P. (Filed by)
TRACON Pharmaceuticals (Subject)
Form SC 13G/A
01/13/2020
7:20 AM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
7:01 AM
TRACON Pharmaceuticals (Filer)
Form 424B5
12/20/2019
6:14 AM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2019
9:47 AM
Puissance Capital Fund LLC (0001695347) (Reporting)
Puissance Capital Management LP (Reporting)
Puissance Cross-Border Opportunities IV LLC (Reporting)
Puissance Cross-Border Opportunities V LLC (Reporting)
TRACON Pharmaceuticals (Issuer)
Wang Theodore T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2019
3:52 PM
TRACON Pharmaceuticals (Filer)
Form 424B3
11/25/2019
3:18 PM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/24/2019
11:15 PM
TRACON Pharmaceuticals (Filer)
Form EFFECT
11/12/2019
3:43 PM
TRACON Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/06/2019
4:08 PM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2019
3:18 PM
TRACON Pharmaceuticals (Filer)
Form DEF 14A
10/21/2019
7:20 AM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2019
4:02 PM
TRACON Pharmaceuticals (Filer)
Form PRE 14A
10/08/2019
11:15 PM
TRACON Pharmaceuticals (Filer)
Form EFFECT
10/03/2019
3:34 PM
TRACON Pharmaceuticals (Filer)
Form S-3/A
09/30/2019
5:24 PM
Brown Scott B. (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/20/2019
3:12 PM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2019
3:20 PM
TRACON Pharmaceuticals (Filer)
Form CT ORDER
09/11/2019
3:16 PM
TRACON Pharmaceuticals (Filer)
Form CT ORDER
09/06/2019
3:18 PM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2019
3:36 PM
TRACON Pharmaceuticals (Filer)
Form S-3/A
08/16/2019
4:01 PM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2019
10:40 AM
THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
4:11 PM
TRACON Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2019
3:11 PM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2019
1:20 PM
TRACON Pharmaceuticals (Issuer)
Walker Paul Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
11:36 AM
LARUE WILLIAM R (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
11:34 AM
MATTINGLY MARTIN A (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
11:32 AM
TRACON Pharmaceuticals (Issuer)
Twiford J Rainer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
11:31 AM
TRACON Pharmaceuticals (Issuer)
WORLAND STEPHEN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:10 PM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2019
4:16 PM
TRACON Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2019
3:14 PM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2019
8:30 PM
LYTTON LAURENCE W (Filed by)
TRACON Pharmaceuticals (Subject)
Form SC 13G/A
04/25/2019
3:05 PM
TRACON Pharmaceuticals (Filer)
Form DEF 14A
04/15/2019
1:48 PM
TRACON Pharmaceuticals (Filer)
Form CT ORDER
04/12/2019
6:04 AM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2019
6:09 PM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2019
8:24 PM
TRACON Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/14/2019
10:45 AM
683 Capital Management, LLC (Filed by)
TRACON Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2019
3:38 PM
Nextech III Oncology, LPCI (Filed by)
TRACON Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2019
11:43 AM
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
TRACON Pharmaceuticals (Subject)
Form SC 13G/A
01/29/2019
12:56 PM
Linden Capital L.P. (Filed by)
TRACON Pharmaceuticals (Subject)
Form SC 13G/A
01/23/2019
3:48 PM
THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
3:05 PM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2018
5:32 PM
THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2018
4:00 PM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2018
9:14 AM
Puissance Capital Fund LLC (0001695347) (Reporting)
Puissance Capital Management LP (Reporting)
Puissance Cross-Border Opportunities IV LLC (Reporting)
Puissance Cross-Border Opportunities V LLC (Reporting)
Puissance Life Science Opportunities Fund VI (Reporting)
TRACON Pharmaceuticals (Issuer)
Wang Theodore T (Reporting)
Form 4/A
12/03/2018
8:39 AM
Puissance Capital Fund LLC (0001695347) (Reporting)
Puissance Capital Management LP (Reporting)
Puissance Cross-Border Opportunities IV LLC (Reporting)
Puissance Cross-Border Opportunities V LLC (Reporting)
Puissance Life Science Opportunities Fund VI (Reporting)
TRACON Pharmaceuticals (Issuer)
Wang Theodore T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2018
4:15 PM
TRACON Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/06/2018
8:29 PM
TRACON Pharmaceuticals (Filer)
Form 424B5
09/06/2018
8:19 PM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2018
4:08 PM
TRACON Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/10/2018
3:09 PM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2018
3:53 PM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2018
7:05 PM
TRACON Pharmaceuticals (Issuer)
Wang Theodore T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2018
7:04 PM
MATTINGLY MARTIN A (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2018
7:04 PM
TRACON Pharmaceuticals (Issuer)
Walker Paul Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2018
7:03 PM
LARUE WILLIAM R (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2018
7:02 PM
TRACON Pharmaceuticals (Issuer)
Twiford J Rainer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2018
7:01 PM
TRACON Pharmaceuticals (Issuer)
WORLAND STEPHEN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2018
3:22 PM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2018
7:04 PM
TRACON Pharmaceuticals (Issuer)
WIGGINS MARK C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2018
6:59 PM
TRACON Pharmaceuticals (Issuer)
WIGGINS MARK C (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/21/2018
11:15 PM
TRACON Pharmaceuticals (Filer)
Form EFFECT
05/21/2018
4:25 PM
TRACON Pharmaceuticals (Filer)
Form 424B3
05/09/2018
3:16 PM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2018
3:58 PM
TRACON Pharmaceuticals (Filer)
Form DEFA14A
04/25/2018
3:51 PM
TRACON Pharmaceuticals (Filer)
Form DEF 14A
04/23/2018
7:00 AM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2018
4:25 PM
Puissance Cross-Border Opportunities V LLC (Filed by)
TRACON Pharmaceuticals (Subject)
Form SC 13D/A
04/10/2018
3:15 PM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2018
3:07 PM
TRACON Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
04/09/2018
7:53 PM
TRACON Pharmaceuticals (Issuer)
Wang Theodore T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2018
3:44 PM
Puissance Capital Fund LLC (0001695347) (Reporting)
Puissance Capital Management LP (Reporting)
Puissance Cross-Border Opportunities IV LLC (Reporting)
Puissance Cross-Border Opportunities V LLC (Reporting)
TRACON Pharmaceuticals (Issuer)
Wang Theodore T (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/02/2018
11:45 AM
Linden Capital L.P. (Filed by)
TRACON Pharmaceuticals (Subject)
Form SC 13G
03/27/2018
3:54 PM
NEA 14 GP, LTD (Reporting)
NEA Partners 14, L.P. (Reporting)
TRACON Pharmaceuticals (Issuer)
Viswanathan Ravi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2018
3:53 PM
NEA 14 GP, LTD (Reporting)
NEA Partners 14, L.P. (Reporting)
Sonsini Peter W. (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2018
3:53 PM
NEA 14 GP, LTD (Reporting)
NEA Partners 14, L.P. (Reporting)
SANDELL SCOTT D (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2018
3:52 PM
MOTT DAVID M (Reporting)
NEA 14 GP, LTD (Reporting)
NEA Partners 14, L.P. (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2018
3:52 PM
KERINS PATRICK J (Reporting)
NEA 14 GP, LTD (Reporting)
NEA Partners 14, L.P. (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2018
3:51 PM
Florence Anthony A. Jr. (Reporting)
NEA 14 GP, LTD (Reporting)
NEA Partners 14, L.P. (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2018
3:51 PM
BASKETT FOREST (Reporting)
NEA 14 GP, LTD (Reporting)
NEA Partners 14, L.P. (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2018
3:51 PM
BARRIS PETER J (Reporting)
NEA 14 GP, LTD (Reporting)
NEA Partners 14, L.P. (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2018
3:50 PM
BARRETT M JAMES (Reporting)
NEA 14 GP, LTD (Reporting)
NEA Partners 14, L.P. (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2018
3:49 PM
NEA 14 GP, LTD (Reporting)
NEA Partners 14, L.P. (Reporting)
New Enterprise Associates 14, L.P. (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2018
7:40 AM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2018
8:59 PM
TRACON Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/23/2018
6:02 PM
BITAR PATRICIA L (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2018
6:01 PM
THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2018
10:42 AM
683 Capital Management, LLC (Filed by)
TRACON Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2018
8:53 AM
LYTTON LAURENCE W (Filed by)
TRACON Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2018
7:21 AM
JAFCO Super V3 Investment Limited Partnership (Filed by)
TRACON Pharmaceuticals (Subject)
Form SC 13G/A
This page was last updated on 2/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel